Results 21 to 30 of about 3,816 (188)

The urgent need for African research collaboration on medicine quality [PDF]

open access: yesNature Communications
Substandard and falsified medicines threaten African health systems, yet research on this crisis is fragmented and concentrated in few countries, predominantly led by Global North institutions.
Fanqi Zeng   +4 more
doaj   +2 more sources

Knowledge, attitudes and practices on substandard and falsified medicines for human and animal use in Wakiso district, Uganda [PDF]

open access: yesJournal of Pharmaceutical Policy and Practice
Background Substandard and falsified medicines (SFMs) continue to pose a significant threat to public health globally. However, there is limited evidence on use of SFMs for both humans and animals particularly in low- and middle-income countries such as ...
David Musoke   +11 more
doaj   +2 more sources

Tinjauan Yuridis terhadap Bidan yang Memperdagangkan Obat Substandar dalam Perspektif Hukum Pidana dan Hukum Pidana Islam (Studi Putusan Nomor 1406/Pid.Sus/2020/PN Mdn)

open access: yesAl-Manhaj, 2023
Substandard medicines trade is a very dangerous crime because it can harm society. This is the background for conducting research on Decision Number 1406/Pid.Sus/2020/Pn Mdn. The purpose of this research is to find out the review of criminal law against
Nafa Fadhilah Hasyim   +2 more
doaj   +1 more source

Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance

open access: yesJMIR Public Health and Surveillance, 2021
The World Health Organization and others warn that substandard and falsified medicines harm health and waste money, especially in low- and middle-income countries.
Elizabeth Pisani   +5 more
doaj   +1 more source

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study

open access: yesPLoS ONE, 2023
The prevalence of substandard and falsified medicines in low- and middle-income countries (LMICs) is a major global public health concern. Multiple screening technologies for post-market surveillance of medicine quality have been developed but there ...
Colleen R. Higgins   +2 more
doaj   +2 more sources

Collaborative reliance in medicine safety and quality regulation: Investigation of experiences in handling N-nitrosamine impurities among ZaZiBoNa participating countries

open access: yesFrontiers in Medicine, 2022
IntroductionThe presence of N-nitrosamine impurities in medicines raised concerns globally as they are genotoxic and probable human carcinogens. A review of N-nitrosamine impurities in medicines provides an opportunity for National Regulatory Authorities
Patience P. Shabangu   +2 more
doaj   +1 more source

Substandard and/or counterfeit medicines for patients

open access: yesBulletin of the World Health Organization, 2007
Subhash C Arya, Nirmala Agarwal
doaj   +1 more source

Substandard and counterfeit medicines: a systematic review of the literature [PDF]

open access: yesBMJ Open, 2013
ObjectiveTo explore the evidence available of poor-quality (counterfeit and substandard) medicines in the literature.DesignSystematic review.Data sourcesDatabases used were EMBASE, MEDLINE, PubMed and the International Pharmaceutical Abstracts, including articles published till January 2013.Eligibility criteriaPrevalence studies containing original ...
Almuzaini, Tariq   +2 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy